Analyzing Viemed Healthcare (NASDAQ:VMD) and Billiontoone (NASDAQ:BLLN)

Viemed Healthcare (NASDAQ:VMD – Get Free Report) and Billiontoone (NASDAQ:BLLN – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation.

Insider & Institutional Ownership

74.2% of Viemed Healthcare shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by insiders. Comparatively, 50.2% of Billiontoone shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Viemed Healthcare and Billiontoone”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Viemed Healthcare $270.28 million 1.19 $14.93 million $0.38 22.42
Billiontoone $305.11 million 14.08 $7.45 million $0.92 97.74

Viemed Healthcare has higher earnings, but lower revenue than Billiontoone. Viemed Healthcare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations and price targets for Viemed Healthcare and Billiontoone, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare 0 4 1 0 2.20
Billiontoone 1 3 7 0 2.55

Viemed Healthcare currently has a consensus target price of $12.00, suggesting a potential upside of 40.85%. Billiontoone has a consensus target price of $124.38, suggesting a potential upside of 38.32%. Given Viemed Healthcare’s higher possible upside, research analysts plainly believe Viemed Healthcare is more favorable than Billiontoone.

Profitability

This table compares Viemed Healthcare and Billiontoone’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Viemed Healthcare 5.03% 10.64% 7.73%
Billiontoone 10.95% 9.16% 6.78%

Summary

Billiontoone beats Viemed Healthcare on 8 of the 13 factors compared between the two stocks.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc. provides in-home respiratory care and related medical equipment to patients with chronic respiratory conditions. Its services are designed to help patients receive respiratory support at home rather than in a hospital or other care facility. The company supplies equipment such as non-invasive ventilators, oxygen systems and airway-clearance devices. Viemed’s respiratory therapists also help patients and caregivers use the equipment and provide ongoing clinical support. Based in the United States, Viemed serves patients in multiple states.

About Billiontoone

(Get Free Report)

BillionToOne is a molecular diagnostics company that develops and provides genetic testing for prenatal care and cancer care. Its tests use the company’s molecular counting technology to detect and measure genetic material in patient samples. In prenatal care, BillionToOne offers screening for chromosomal conditions and certain inherited single-gene disorders. Its UNITY platform includes tests designed to assess fetal risk using a pregnant patient’s blood sample. The company also provides oncology testing, including services designed to help characterize tumors and detect cancer-related genetic material.

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.